Management of Acute Myocardial Infarction with Hypotension and Bradycardia

Immediate Hemodynamic Stabilization

• The European Society of Cardiology recommends immediate emergency angiography and PCI for STEMI complicated by cardiogenic shock, with urgent hemodynamic support using IV fluids and atropine for symptomatic bradycardia, while strictly avoiding beta-blockers and initiating dual antiplatelet therapy with aspirin plus ticagrelor or prasugrel in patients with hypotension and bradycardia 1, 2
• Intravenous beta-blockers must be avoided in patients with hypotension, acute heart failure, or severe bradycardia, as recommended by the European Society of Cardiology 1, 2
• Administer atropine 0.5-1 mg IV for symptomatic bradycardia (pulse 50 bpm with hypotension) in patients with acute myocardial infarction, as recommended by the European Society of Cardiology 1
• Consider temporary pacing if bradycardia persists despite atropine, particularly with inferior STEMI and RV involvement, as recommended by the European Society of Cardiology 1
• Administer IV normal saline boluses (500-1000 mL) to maintain preload in suspected RV infarction, as recommended by the European Society of Cardiology 1
• Monitor closely for pulmonary edema, though clear lungs suggest adequate RV function compensation in patients with acute myocardial infarction, as recommended by the European Society of Cardiology 1

Emergency Reperfusion Strategy

• The European Society of Cardiology recommends emergency angiography and PCI if indicated in patients with heart failure/shock, with a goal of reducing mortality and improving outcomes 1, 2
• This patient meets criteria for cardiogenic shock (hypotension with JVD) requiring immediate catheterization, as recommended by the European Society of Cardiology 1, 2
• Transfer to PCI-capable center immediately if not already at one, as recommended by the European Society of Cardiology 1

Antithrombotic Therapy

• The European Society of Cardiology recommends dual antiplatelet therapy in the form of aspirin plus ticagrelor or prasugrel (or clopidogrel if ticagrelor or prasugrel are not available or are contraindicated) in patients with acute myocardial infarction, with a goal of reducing recurrent ischemic events 1, 2
• Aspirin 162-325 mg loading dose (chewed for faster absorption) is recommended by the European Society of Cardiology in patients with acute myocardial infarction 1, 3
• Unfractionated heparin (UFH) given as weight-adjusted IV bolus (60-70 units/kg, max 5000 units) followed by infusion (12-15 units/kg/hr, max 1000 units/hr) is recommended by the European Society of Cardiology in patients with acute myocardial infarction 1

Critical Pitfalls to Avoid

• Never administer beta-blockers (oral or IV) in the acute setting with hypotension, bradycardia, or heart failure, as recommended by the European Society of Cardiology 1, 2
• Do not delay catheterization for "medical stabilization" in cardiogenic shock—immediate PCI improves mortality, as recommended by the European Society of Cardiology 1, 2

Post-PCI Medical Therapy

• The European Society of Cardiology recommends ACE inhibitors, starting within the first 24 hours of STEMI in patients with evidence of heart failure, LV systolic dysfunction, diabetes, or an anterior infarct, with a goal of reducing mortality and improving outcomes 1, 2
• Oral treatment with beta-blockers is indicated in patients with heart failure and/or LVEF <40% unless contraindicated, as recommended by the European Society of Cardiology 1, 2
• It is recommended to start high-intensity statin therapy as early as possible, unless contraindicated, and maintain it long-term, as recommended by the European Society of Cardiology 1, 2
• Target LDL-C <1.8 mmol/L (70 mg/dL) or reduction of at least 50%, as recommended by the European Society of Cardiology 1, 4

Duration of Antiplatelet Therapy

• The European Society of Cardiology recommends DAPT for 12 months after PCI, unless there are contraindications such as excessive risk of bleeding, with a goal of reducing recurrent ischemic events 1, 2, 5
• After 12 months, continue aspirin 75-100 mg daily indefinitely, as recommended by the European Society of Cardiology 1, 4
• A PPI in combination with DAPT is recommended in patients at high risk of gastrointestinal bleeding, as recommended by the European Society of Cardiology 1, 2

Risk Stratification Post-Procedure

• Routine echocardiography during hospital stay to assess resting LV and RV function, detect early post-MI mechanical complications, and exclude LV thrombus is recommended in all patients, as recommended by the European Society of Cardiology 1, 2

Management of Post‑Thrombolysis Hypotension in Acute Myocardial Infarction

Immediate Clinical Assessment

• Low jugular venous pressure (JVP) with clear lung fields indicates hypovolemia, whereas elevated JVP with clear lungs suggests right‑ventricular (RV) infarction and elevated JVP with pulmonary edema points to cardiogenic shock. 6, 7
• Bradycardia accompanied by hypotension (“warm hypotension”) is characteristic of a vagal reaction, most often seen in inferior myocardial infarction. 6
• Hypotension that appears within 10–20 minutes of streptokinase infusion and resolves spontaneously is diagnostic of streptokinase‑induced (benign) hypotension. 8
• ST‑segment elevation ≥1 mm in right‑sided lead V4R on a 12‑lead ECG is highly predictive of RV infarction. 9

Etiology‑Specific Management

1. Streptokinase‑Induced (Benign) Hypotension

• Temporarily stop the streptokinase infusion, place the patient supine, and elevate the feet; blood pressure usually normalises within ≈ 16 ± 6 minutes. 8
• If needed, give a small dose of atropine or a brief fluid bolus; do not discontinue streptokinase because it does not impair reperfusion, increase cardiogenic‑shock rates, or raise mortality. 8

2. Hypovolemia

• Administer rapid intravenous normal‑saline boluses of 500–1000 mL, titrating to avoid pulmonary congestion. 10, 7
• Aim for a pulmonary artery wedge pressure (PAWP) of ≥15 mm Hg to ensure adequate preload. 6, 7

3. Right‑Ventricular Infarction

• Give aggressive intravenous fluid (normal saline) to maintain elevated right‑sided filling pressures and support cardiac output. 7, 9
• Use atropine 0.5–1 mg IV for symptomatic bradycardia; consider temporary pacing if bradycardia persists. 6
• Avoid diuretics and vasodilators (including nitrates) because they can precipitate severe hypotension. 7
• If fluid therapy fails, add dobutamine 2.5–10 µg kg⁻¹ min⁻¹ or consider intra‑aortic balloon pump support. 7

4. Cardiogenic Shock / Pump Failure

• Insert a pulmonary‑artery catheter immediately (Class I) for haemodynamic profiling. 10, 9
• Target PAWP < 20 mm Hg and cardiac index > 2 L min⁻¹ m⁻². 6
• Provide supplemental oxygen; intubate if PaO₂ < 60 mm Hg despite 100 % O₂. 6
• Inotropic strategy:
  
  • Dopamine 2.5–5 µg kg⁻¹ min⁻¹ when renal hypoperfusion predominates. 6
  • Dobutamine 2.5–10 µg kg⁻¹ min⁻¹ when pulmonary congestion predominates. 6, 7
• Unless the patient is already hypotensive, start IV nitroglycerin at 0.25 µg kg⁻¹ min⁻¹ and titrate every 5 minutes to a systolic BP of ≈ 90 mm Hg. 6
• Administer a loop diuretic as needed. 6
• Class I recommendation: emergent coronary angiography with percutaneous coronary intervention (PCI) (or CABG) improves survival in shock not rapidly reversed by drugs. 10, 9

5. Bradycardia‑Hypotension (Vagal Reaction)

• Give atropine 0.5–1 mg IV; if ineffective, proceed to temporary pacing. 6
• This pattern is frequently observed in inferior MI or after opioid administration. 6

Mechanical Complications to Exclude

• Perform urgent bedside echocardiography to rule out:
  
  • Acute mitral regurgitation (papillary‑muscle rupture)
  • Ventricular septal defect
  • Free‑wall rupture with tamponade physiology
  • Isolated RV dysfunction
• Detection of any of these complications mandates emergency surgical consultation and a Class I indication for intra‑aortic balloon pump as a bridge to surgery. 10, 9, 6, 7

Hemodynamic Monitoring Indications

• Pulmonary‑artery catheterisation is Class I for:
  
  • Cardiogenic shock unresponsive to initial pharmacologic therapy
  • Persistent hypotension despite fluids when pulmonary congestion is absent
  • Suspected mechanical complications (e.g., rupture, septal defect)
  • Severe or progressive heart failure
• The catheter differentiates low filling pressure (volume depletion) from high filling pressure (LV dysfunction), guiding opposite therapeutic approaches. 10, 9

Post‑Stabilisation Strategy

• Once haemodynamically stable, proceed without delay to definitive reperfusion (emergent angiography with PCI or CABG) for patients in cardiogenic shock, as this reduces mortality. 10

All statements are supported by the cited references; where a Class I recommendation is noted, it reflects the highest level of guideline endorsement in the source literature.